COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin (ODIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01701180
Recruitment Status : Completed
First Posted : October 4, 2012
Last Update Posted : December 3, 2014
Information provided by (Responsible Party):
Rene Hurlemann, University Hospital, Bonn

Brief Summary:
Mounting evidence indicates that the intranasal administration of the neuropeptide oxytocin has prosocial effects. However, the neural substrates of these effects are still unclear. The investigators hypothesized that a single dose administration of oxytocin should increase empathogenic and affiliative responses and that these effects are mediated by an increased insula activity.

Condition or disease Intervention/treatment Phase
Healthy Drug: Oxytocin Drug: Placebo Early Phase 1

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Neural Correlates of the Empathogenic and Affiliative Actions of Oxytocin
Study Start Date : August 2012
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

Drug Information available for: Oxytocin

Arm Intervention/treatment
Experimental: Oxytocin
24 IU Oxytocin, intranasal application 45 min prior to the experiment
Drug: Oxytocin
24 IU; 3 puffs per nostril, each with 4 IU OXT
Other Name: Oxytocin: Syntocinon-Spray, Novartis

Placebo Comparator: Placebo
Intranasal application, sodium chloride solution, 3 puffs per nostril
Drug: Placebo

Primary Outcome Measures :
  1. Empathy ratings and their neural correlates [ Time Frame: About one hour after the intranasal administration of oxytocin ]
    All subjects are scanned while they view emotional and neutral faces and rate their empathy for these stimuli.

Secondary Outcome Measures :
  1. Neural correlates of pair-bonding [ Time Frame: About one hour after the intranasal administration of oxytocin ]
    All subjects are scanned while they view a picture of their mate and and an unknown female.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy male volunteers
  • In a heterosexual relationship

Exclusion Criteria:

  • Current or past psychiatric disease
  • Current or past physical illness
  • Psychoactive medication
  • Tobacco smokers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01701180

Layout table for location information
Department of Psychiatry, University of Bonn
Bonn, North Rhine-Westphalia, Germany, 53105
Sponsors and Collaborators
University Hospital, Bonn
Layout table for investigator information
Principal Investigator: René Hurlemann, MD PhD M.Sc. Department of Psychiatry University of Bonn
Additional Information:
Layout table for additonal information
Responsible Party: Rene Hurlemann, MSc MD PhD, University Hospital, Bonn Identifier: NCT01701180    
Other Study ID Numbers: OXT-151/12
OXT-151/12 ( Other Grant/Funding Number: HU1302/2-2 and NEMO )
First Posted: October 4, 2012    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014
Keywords provided by Rene Hurlemann, University Hospital, Bonn:
Male Volunteers
Additional relevant MeSH terms:
Layout table for MeSH terms
Reproductive Control Agents
Physiological Effects of Drugs